Press Releases

  • March 10, 2020

    Multi-Center, Real World Study of PROCEPT BioRobotics’ Aquablation Therapy for BPH Replicates Outcomes From Clinical Studies

    One-year results from the OPEN WATER trial published in the Journal of Clinical Medicine REDWOOD City, Calif. – March 10, 2020 – PROCEPT BioRobotics Corporation, a surgical robotics company developing intellig... Read more

  • February 27, 2020

    PROCEPT BioRobotics Announces Three-Year Follow-Up Data Confirming Sustained Efficacy, Superior Safety of Aquablation® Therapy for Benign Prostatic Hyperplasia

    REDWOOD CITY, Calif. – (BUSINESS WIRE) – PROCEPT BioRobotics Corporation, a surgical robotics company developing intelligent solutions to transform the field of urology, has announced that three-year follow-up... Read more

  • February 6, 2020

    PROCEPT BioRobotics Appoints Reza Zadno, PhD, as New President and CEO

    Industry Veteran Brings Deep Expertise in Leading and Scaling Commercial Operations in Medical Device Companies REDWOOD City, Calif. – Feb. 6, 2020 – PROCEPT BioRobotics Corporation, a Silicon Valley surgical ... Read more

  • November 6, 2019

    PROCEPT BioRobotics’ AquaBeam® Robotic System Receives CMS Approval for Transitional Pass-Through Payment Status

    Incremental Reimbursement in Outpatient Setting Will Expand Availability of Transformative Next-Generation Benign Prostatic Hyperplasia (BPH) Treatment   REDWOOD SHORES, Calif. – November 06, 2019 —... Read more

  • May 20, 2019

    PROCEPT BioRobotics Announces New Clinical and Real-World Data Highlighting Effectiveness, Durability, Superior Safety and Reproducibility of Aquablation Therapy for BPH

    Results Presented at AUA 2019 Support Use in a Broad Range of Patient Populations REDWOOD SHORES, Calif. – May 20, 2019 – New clinical data presented at the American Urological Association (AUA) Annual Meeting c... Read more

  • May 3, 2019

    AUA Amends Clinical Practice Guidelines to Include PROCEPT BioRobotics’ Aquablation Therapy as a Standard of Care Option for the Treatment of Enlarged Prostate

    Robotic, Heat-Free Surgical Technique Delivers Reduced Rate of Sexual Side Effects with Gold Standard Efficacy  REDWOOD SHORES, Calif. – May 3, 2019 – PROCEPT® BioRobotics, a Silicon Valley surgical robotics c... Read more

  • November 7, 2018

    PROCEPT BioRobotics Appoints Kevin Waters as Chief Financial Officer

    REDWOOD SHORES, Calif. –  November 7, 2018 – PROCEPT BioRobotics today announced the appointment of Kevin Waters as chief financial officer. Mr. Waters brings approximately 20 years of finance and medical devic... Read more

  • October 1, 2018

    PROCEPT BioRobotics’ Aquablation Therapy Expands Global Market Access with NICE Guidance and NTAP Incremental Payment

    Enhanced Guidance and Incremental Reimbursement Will Strengthen Continued Global Growth of Aquablation Therapy for the Treatment for Benign Prostatic Hyperplasia (BPH)  REDWOOD SHORES, Calif. – October 1, 2018 ... Read more

  • June 18, 2018

    PROCEPT BioRobotics Named 2018 MedTech Breakthrough Award Winner

    PROCEPT BioRobotics’ AQUABEAM System Recognized with “Best Healthcare Robotics Solution” Award REDWOOD SHORES, Calif. –June 19, 2018 – PROCEPT BioRobotics today announced that it has been selected as the ... Read more

  • December 21, 2017

    FDA Grants De Novo Request for PROCEPT BioRobotics AquaBeam System

    System’s Aquablation® Technology Offers Heat-free Robotic Alternative for the Minimally Invasive Treatment of Benign Prostatic Hyperplasia (BPH) REDWOOD SHORES, Calif. – Dec. 21, 2017 – PROCEPT BioRobotics , ... Read more

  • October 31, 2017

    PROCEPT BioRobotics Announces Milestones in Europe: First Commercial Aquablation Cases Completed in Germany and Initiation of FRANCAIS WATER Clinical Trial

    REDWOOD SHORES, Calif. – October 31, 2017 – PROCEPT BioRobotics, a Silicon Valley surgical robotics company developing novel and disruptive technologies to treat prostate disease, announced that the first commer... Read more

  • September 27, 2017

    PROCEPT BioRobotics Announces First Patients Treated in WATER II Pivotal Clinical Trial

    PROCEPT BioRobotics Announces First Patients Treated in WATER II Pivotal Clinical Trial Study Will Evaluate the Safety and Efficacy of Aquablation in Large Prostates for Patients with Lower Urinary Tract Symptoms Du... Read more

  • October 27, 2016

    PROCEPT BioRobotics Announces Educational Support for 2017 American Urological Association Visiting Scholar Program

    A collaborative and exciting program that fosters the alliance between the AUA, BAUS and DGU, assisting in identifying future leaders within those organizations REDWOOD SHORES, California, October 27, 2016 – PROCE... Read more

  • December 15, 2015

    PROCEPT BioRobotics Announces First Patients Treated in Global IDE Clinical Trial for BPH

    WATER Study to evaluate the effectiveness and safety of Aquablation in the targeted and heat-free resection of prostate tissue REDWOOD SHORES, California, December 3, 2015 – PROCEPT BioRobotics, a medical device c... Read more

  • July 7, 2015

    PROCEPT BioRobotics Announces Closing of $42 Million in New Funding

    Financing to Support Phase III Clinical Trial and International Commercialization of AQUABEAM® for the Treatment of Benign Prostatic Hyperplasia REDWOOD SHORES, California, July 7, 2015 – PROCEPT BioRobotics, a p... Read more

  • May 15, 2015

    PROCEPT BioRobotics Presents Phase II Data on Treatment of Benign Prostatic Hyperplasia with Aquablation using the AquaBeam®

    Data demonstrate the performance and the preliminary safety and effectiveness of a novel image-guided robotic surgical system that uses high velocity saline to efficiently resect prostate tissue REDWOOD SHORES, Cali... Read more

  • Media Contact

    Get in Touch

    Nobles Global Communications
    +1 (818) 618 5634

    Media Contact

    Get in Touch

    Nobles Global Communications
    +1 (818) 618 5634